Related Experiment Video
Updated: Jul 28, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
CD26 CAR-T cells have attenuated mitochondrial and glycolytic metabolic profiling
Xiaoying Zhu1,2,3, Zhaodong Zhong1, Fankai Meng4
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Background:
Multiple targets of chimeric antigen receptor T cells (CAR-T cells) are shared expressed by tumor cells and T cells, these self-antigens may stimulate CAR-T cells continuously during the expansion. Persistent exposure to antigens is considered to cause metabolic reprogramming of T cells and the metabolic profiling is critical in determining the cell fate and effector function of CAR-T cells. However, whether the stimulation of self-antigens during CAR-T cell generation could remodel the metabolic profiling is unclear. In this study, we aim to investigate the metabolic characteristics of CD26 CAR-T cells, which expressed CD26 antigens themselves.
Methods:
The mitochondrial biogenesis of CD26 and CD19 CAR-T cells during expansion was evaluated by the mitochondrial content, mitochondrial DNA copy numbers and genes involved in mitochondrial regulation. The metabolic profiling was investigated by the ATP production, mitochondrial quality and the expression of metabolism-related genes. Furthermore, we assessed the phenotypes of CAR-T cells through memory-related markers.
Results:
We reported that CD26 CAR-T cells had elevated mitochondrial biogenesis, ATP production and oxidative phosphorylation at early expansion stage. However, the mitochondrial biogenesis, mitochondrial quality, oxidative phosphorylation and glycolytic activity were all weakened at later expansion stage. On the contrary, CD19 CAR-T cells did not exhibit such characteristics.
Conclusion:
CD26 CAR-T cells showed distinctive metabolic profiling during expansion that was extremely unfavorable to cell persistence and function. These findings may provide new insights for the optimization of CD26 CAR-T cells in terms of metabolism.
Insights
Chimeric antigen receptor T (CAR-T) cells targeting CD26 exhibit unfavorable metabolic changes during expansion due to self-antigen stimulation. This impacts their persistence and function, suggesting a need for metabolic optimization strategies.
Area of Science:
- Immunology
- Cell Biology
- Metabolic Engineering
Background:
- Chimeric antigen receptor T (CAR-T) cells can be continuously stimulated by self-antigens shared between tumor and T cells.
- Persistent antigen exposure can lead to metabolic reprogramming, influencing CAR-T cell fate and function.
- The impact of self-antigen stimulation on CAR-T cell metabolic profiling during generation remains unclear.
Purpose of the Study:
- To investigate the metabolic characteristics of CD26 CAR-T cells, which express the CD26 self-antigen.
- To determine if self-antigen expression influences CAR-T cell metabolism and function.
Main Methods:
- Evaluated mitochondrial biogenesis (content, mtDNA copy number, regulatory genes) in CD26 and CD19 CAR-T cells.
- Assessed metabolic profiling via ATP production, mitochondrial quality, and metabolism-related gene expression.
- Analyzed CAR-T cell phenotypes using memory-related markers.
Main Results:
- CD26 CAR-T cells showed increased mitochondrial biogenesis, ATP production, and oxidative phosphorylation early in expansion.
- At later stages, CD26 CAR-T cells exhibited weakened mitochondrial biogenesis, quality, oxidative phosphorylation, and glycolytic activity.
- CD19 CAR-T cells did not display these metabolic alterations.
Conclusions:
- CD26 CAR-T cells possess a distinct metabolic profile during expansion that is detrimental to their persistence and effector functions.
- Findings offer insights for optimizing CD26 CAR-T cell metabolism for improved therapeutic outcomes.
More Related Videos
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
08:09Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level
Published on: March 14, 2025